Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Low-density lipoprotein cholesterol and the risk of dementia with stroke.

Moroney JT, Tang MX, Berglund L, Small S, Merchant C, Bell K, Stern Y, Mayeux R.

JAMA. 1999 Jul 21;282(3):254-60.

PMID:
10422994
2.

Relationship between plasma lipids and all-cause mortality in nondemented elderly.

Schupf N, Costa R, Luchsinger J, Tang MX, Lee JH, Mayeux R.

J Am Geriatr Soc. 2005 Feb;53(2):219-26.

PMID:
15673344
3.

Contribution of vascular risk factors to the progression in Alzheimer disease.

Helzner EP, Luchsinger JA, Scarmeas N, Cosentino S, Brickman AM, Glymour MM, Stern Y.

Arch Neurol. 2009 Mar;66(3):343-8. doi: 10.1001/archneur.66.3.343.

4.

Effect of serum lipids, lipoproteins, and apolipoproteins on vascular and nonvascular mortality in the elderly.

Räihä I, Marniemi J, Puukka P, Toikka T, Ehnholm C, Sourander L.

Arterioscler Thromb Vasc Biol. 1997 Jul;17(7):1224-32.

5.

Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study.

Zimetbaum P, Frishman WH, Ooi WL, Derman MP, Aronson M, Gidez LI, Eder HA.

Arterioscler Thromb. 1992 Apr;12(4):416-23.

6.

Role of non-high-density lipoprotein cholesterol in predicting cerebrovascular events in patients following myocardial infarction.

Mahajan N, Ference BA, Arora N, Madhavan R, Bhattacharya P, Sudhakar R, Sagar A, Wang Y, Sacks F, Afonso L.

Am J Cardiol. 2012 Jun 15;109(12):1694-9. doi: 10.1016/j.amjcard.2012.02.010. Epub 2012 Mar 31.

PMID:
22465317
7.

Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.

Schilling S, Tzourio C, Soumaré A, Kaffashian S, Dartigues JF, Ancelin ML, Samieri C, Dufouil C, Debette S.

PLoS Med. 2017 Mar 28;14(3):e1002265. doi: 10.1371/journal.pmed.1002265. eCollection 2017 Mar.

8.

Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism.

Pedro-Botet J, Sentí M, Nogués X, Rubiés-Prat J, Roquer J, D'Olhaberriague L, Olivé J.

Stroke. 1992 Nov;23(11):1556-62.

9.

Relation of plasma lipids to Alzheimer disease and vascular dementia.

Reitz C, Tang MX, Luchsinger J, Mayeux R.

Arch Neurol. 2004 May;61(5):705-14.

10.

High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.

Weverling-Rijnsburger AW, Jonkers IJ, van Exel E, Gussekloo J, Westendorp RG.

Arch Intern Med. 2003 Jul 14;163(13):1549-54.

PMID:
12860577
11.
13.

Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.

Nakamura T, Obata JE, Hirano M, Kitta Y, Fujioka D, Saito Y, Kawabata K, Watanabe K, Watanabe Y, Mishina H, Kugiyama K.

Atherosclerosis. 2011 Sep;218(1):163-7. doi: 10.1016/j.atherosclerosis.2011.04.040. Epub 2011 May 6.

PMID:
21605862
14.

Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease.

Lamarche B, Tchernof A, Mauriège P, Cantin B, Dagenais GR, Lupien PJ, Després JP.

JAMA. 1998 Jun 24;279(24):1955-61.

PMID:
9643858
15.

Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study.

Bikkina M, Levy D, Evans JC, Larson MG, Benjamin EJ, Wolf PA, Castelli WP.

JAMA. 1994 Jul 6;272(1):33-6.

PMID:
8007076
16.

Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study.

Zuliani G, Cavalieri M, Galvani M, Volpato S, Cherubini A, Bandinelli S, Corsi AM, Lauretani F, Guralnik JM, Fellin R, Ferrucci L.

J Gerontol A Biol Sci Med Sci. 2010 May;65(5):559-64. doi: 10.1093/gerona/glq026. Epub 2010 Mar 18.

17.

Apolipoprotein E genotype and lipid and lipoprotein levels in dementia.

Wehr H, Parnowski T, Puzyński S, Bednarska-Makaruk M, Bisko M, Kotapka-Minc S, Rodo M, Wołkowska M.

Dement Geriatr Cogn Disord. 2000 Mar-Apr;11(2):70-3.

PMID:
10705163
18.

Gender and genotype modulation of the association between lipid levels and depressive symptomatology in community-dwelling elderly (the ESPRIT study).

Ancelin ML, Carrière I, Boulenger JP, Malafosse A, Stewart R, Cristol JP, Ritchie K, Chaudieu I, Dupuy AM.

Biol Psychiatry. 2010 Jul 15;68(2):125-32. doi: 10.1016/j.biopsych.2010.04.011. Epub 2010 May 26.

19.

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr.

JAMA. 1998 May 27;279(20):1615-22.

PMID:
9613910
20.

Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders.

Ferreira CN, Carvalho MG, Fernandes AP, Lima LM, Loures-Valle AA, Dantas J, Janka Z, Palotás A, Sousa MO.

Neurochem Int. 2010 Jan;56(1):177-82. doi: 10.1016/j.neuint.2009.09.016. Epub 2009 Oct 9.

PMID:
19819279

Supplemental Content

Support Center